Page last updated: 2024-08-16

resveratrol and Lymphoma

resveratrol has been researched along with Lymphoma in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's5 (62.50)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Alwan, AF; Hasan, ZYM; Jasim, AA; Obed, FAA1
Frazzi, R; Guardi, M1
Atadja, P; Buettner, R; Cermak, JM; Jove, R; Kirschbaum, M; Kujawski, M; Scuto, A1
Frazzi, R; Tigano, M1
Bhat, AA; Khan, OS; Krishnankutty, R; Mohammad, RM; Uddin, S1
Athar, M; Back, JH; Bickers, DR; Kim, AL; Kopelovich, L1
Guan, H; Hegde, VL; Hofseth, L; Nagarkatti, M; Nagarkatti, PS; Singh, NP; Singh, UP1
Lehmann, L; Metzler, M; Schmitt, E; Stopper, H1

Reviews

4 review(s) available for resveratrol and Lymphoma

ArticleYear
Cellular and Molecular Targets of Resveratrol on Lymphoma and Leukemia Cells.
    Molecules (Basel, Switzerland), 2017, May-27, Volume: 22, Issue:6

    Topics: Anticarcinogenic Agents; Humans; Leukemia; Lymphoma; Resveratrol; Stilbenes

2017
The multiple mechanisms of cell death triggered by resveratrol in lymphoma and leukemia.
    International journal of molecular sciences, 2014, Mar-20, Volume: 15, Issue:3

    Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Biomarkers, Tumor; Cell Line, Tumor; Humans; Leukemia; Lymphoma; Models, Biological; Resveratrol; Stilbenes

2014
Therapeutic Potential of Resveratrol in Lymphoid Malignancies.
    Nutrition and cancer, 2016, Volume: 68, Issue:3

    Topics: Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Humans; Lymphoma; Multiple Myeloma; Resveratrol; Stilbenes

2016
Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms.
    Archives of biochemistry and biophysics, 2009, Jun-15, Volume: 486, Issue:2

    Topics: Anticarcinogenic Agents; Breast Neoplasms; Cathepsins; Cell Cycle; Cell Division; Female; Humans; Inflammation; Leukemia; Lymphoma; Male; Neoplasms; Prostatic Neoplasms; Resveratrol; Safety; Stilbenes; Transcription Factors

2009

Other Studies

4 other study(ies) available for resveratrol and Lymphoma

ArticleYear
    Journal of medicine and life, 2022, Volume: 15, Issue:6

    Topics: Cytokines; Humans; Interleukin-10; Iraq; Lymphocytes; Lymphoma; Resveratrol; Tumor Necrosis Factor-alpha; Vitis

2022
SIRT1 activation enhances HDAC inhibition-mediated upregulation of GADD45G by repressing the binding of NF-κB/STAT3 complex to its promoter in malignant lymphoid cells.
    Cell death & disease, 2013, May-16, Volume: 4

    Topics: Acetylation; Apoptosis; Cell Line, Tumor; Enzyme Inhibitors; GADD45 Proteins; Heterocyclic Compounds, 4 or More Rings; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Hydroxamic Acids; Indoles; Intracellular Signaling Peptides and Proteins; Lymphoma; NF-kappa B; Panobinostat; Phosphorylation; Promoter Regions, Genetic; Protein Binding; Proto-Oncogene Proteins c-myc; Resveratrol; RNA Interference; RNA, Small Interfering; Sirtuin 1; STAT3 Transcription Factor; Stilbenes; Up-Regulation

2013
Resveratrol (trans-3,5,4'-trihydroxystilbene) suppresses EL4 tumor growth by induction of apoptosis involving reciprocal regulation of SIRT1 and NF-κB.
    Molecular nutrition & food research, 2011, Volume: 55, Issue:8

    Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Fas Ligand Protein; fas Receptor; Gene Expression Regulation, Neoplastic; Lymphoma; Mice; Mice, Inbred NOD; Mice, SCID; NF-kappa B; Receptors, Aryl Hydrocarbon; Resveratrol; Sirtuin 1; Stilbenes

2011
Hormonal and genotoxic activity of resveratrol.
    Toxicology letters, 2002, Dec-15, Volume: 136, Issue:2

    Topics: Animals; Breast Neoplasms; Cell Cycle; Cell Division; Cell Survival; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Estrogen Receptor alpha; Fluorescein-5-isothiocyanate; Humans; Kinetochores; Lymphoma; Metaphase; Mice; Micronucleus Tests; Molecular Structure; Protein Binding; Receptors, Estrogen; Resveratrol; Stilbenes; Time Factors; Tubulin; Tumor Cells, Cultured

2002